Cargando…
The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
INTRODUCTION: Understanding the clinical potency of latency-reversing agents (LRAs) on the HIV-1 reservoir is useful to deploy future strategies. This systematic review evaluated the effects of LRAs in human intervention studies. METHODS: A literature search was performed using medical databases foc...
Autores principales: | Debrabander, Quinten, Hensley, Kathryn S., Psomas, Christina K., Bramer, Wichor, Mahmoudi, Tokameh, van Welzen, Berend J., Verbon, Annelies, Rokx, Casper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474473/ https://www.ncbi.nlm.nih.gov/pubmed/37663575 http://dx.doi.org/10.1016/j.jve.2023.100342 |
Ejemplares similares
-
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
por: Stoszko, Mateusz, et al.
Publicado: (2015) -
Towards the next step: LoViRet patients for HIV-1 cure studies
por: Crespo, Raquel, et al.
Publicado: (2020) -
The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012) -
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
por: Ne, Enrico, et al.
Publicado: (2022) -
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency
por: Stoszko, Mateusz, et al.
Publicado: (2020)